Aromatase Inhibitors and Weight Loss in Severely Obese Men With Hypogonadism

NCT03490513 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

121

Enrollment

OTHER

Sponsor class

Conditions

Hypogonadism, Hypogonadotropic
Obesity

Interventions

DRUG: anastrozole (1 mg/day)
DRUG: Placebo

Sponsor

Baylor College of Medicine